Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
Spinal cord injury (SCI) is an extremely serious type of physical trauma observed in clinics. Neuropathic pain resulting from SCI has a lasting and significant impact on most aspects of daily life. Thus, a better understanding of the molecular pathways responsible for the cause of neuropathic pain o...
Guardado en:
Autores principales: | Wang Xiaoping, Li Xiaojia, Huang Bin, Ma Shuai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5583841c648a4ac6bc5740f06e939308 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
por: Yoon MS
Publicado: (2020) -
Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
por: Preeti Vyas, et al.
Publicado: (2021) -
Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
por: Wang Xu, et al.
Publicado: (2016) -
mTOR pathway: A potential therapeutic target for spinal cord injury
por: Yi Ding, et al.
Publicado: (2022) -
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
por: Terry Ting-Yu Chiou, et al.
Publicado: (2021)